Glaukos Corporation
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
See below for the Latest Glaukos Corporation News, Analysis, Profit Results, Share Price Information, and Commentary.
Micro stents, macro efficiency: How a tiny device helps preserve vision
Glaukos Corporation’s iStent inject W helps preserve vision by addressing high eye pressure.
Micro stents, macro efficiency: How a tiny device helps preserve vision
Glaukos Corporation’s iStent inject W helps preserve vision by addressing high eye pressure.
Most Read
1. Healthsprings unveils new platform for telemedicine services in Singapore 2. Evolving the Healthcare landscape in Singapore with Integrated Ambulatory Surgical Centres 3. IHH Healthcare Malaysia secures 4 wins, including 2 awards for Prince Court Medical Centre, at Healthcare Asia Awards 2024 4. Q&M adopts intraoral scanner for improved dental care 5. Hong Kong and Shanghai eye stronger healthcare collaborationResource Center
Read Here
Advertise
Sign Up
Event News
Event News
Bumrungrad International Hospital marks 2023 journey with outstanding achievements, transformative leadership
![Bumrungrad International Hospital marks 2023 journey with outstanding achievements, transformative leadership]()
Co-Written / Partner
It remains committed to advancing healthcare standards and creating a lasting impact on the community.
It remains committed to advancing healthcare standards and creating a lasting impact on the community.
Commentary
Evolving the Healthcare landscape in Singapore with Integrated Ambulatory Surgical Centres